Possible Trump FDA Commish Candidate Favors (Much) Lighter Touch

Jim O'Neill, a Silicon Valley investment manager, would be an unusual choice to head FDA, not just because he isn’t a physician, but because he’s favored substantially reducing FDA's role in assessing product effectiveness. While some experts are highly skeptical about O'Neill, who worked at HHS in the Bush administration, others suggest he could champion much-needed change at the agency.

Capitol House

A purported candidate to run FDA under the Trump administration would bring what some consider troubling views and experience to the commissioner post, but regulatory affairs stakeholders say Silicon Valley investor Jim O'Neill could be an interesting pick.

President-elect Donald Trump is reportedly considering replacing FDA Commissioner Robert Califf with O'Neill, an associate of controversial Silicon Valley billionaire...

HBW Podcast

Explore how consumer health is evolving. On the go.

David Ridley hosts in-depth conversations with industry leaders.

More from Leadership

HI-Leadership (Premium-2): Melatonin, Omega 3 & Dietary Supplements: ADHD Hype or Help?

 
• By 

Two experts examine whether melatonin, omega-3, dietary supplements, vitamins, and minerals truly benefit adults with ADHD. While some supplements show promise in supporting brain health, scientific evidence for their effectiveness in improving ADHD symptoms remains limited.

Dermapharm Makes Changes To Turn Around Arkopharma’s Performance

 
• By 

Intensified competition in the dietary supplements market and consumers squeezed by cost-of-living pressures held back sales at Dermapharm's Arkopharma subsidiary in the first half. A leadership change, along with a renewed focus on commercial excellence, is hoped by Dermapharm to turn the business around.

‘Inside Regulatory Affairs’ With Kenvue's Kevin Whelan

This HBW Insight series profiles regulatory affairs specialists working in or supporting the consumer health and beauty product industries. In this installment, we speak to Kenvue's Kevin Whelan.

Estee Lauder Companies’ Freda To Exit In 2025 With Dreary Forecast For Fiscal New Year

 

The beauty giant expects organic sales growth for fiscal 2025 to range between -1% and 2%, falling well short of analyst consensus of 7.2%, reflecting the firm’s overexposure in China and Asia travel retail. A new CEO is incoming with Fabrizio Freda set to step down in June 2025.

More from HBW Insight

data

Type:DataArticle | Publication:HBW | Section:Health | Paywall:Premium — Article containing all Composer content for testing (Do not update)

 
• By 

To make your document look professionally produced, Word provides header, footer, cover page, and text box designs that complement each other. For example, you can add a matching cover page, header, and sidebar. Click Insert and then choose the elements you want from the different galleries.

Test: PDF Link Lifetime

Description description

headline test

description